Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
149.70
-1.05 (-0.70%)
Official Closing Price
Updated: 4:10 PM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,157,578
Open
149.67
Bid (Size)
148.48 (100)
Ask (Size)
150.75 (100)
Prev. Close
150.75
Today's Range
149.31 - 151.11
52wk Range
97.72 - 170.46
Shares Outstanding
N/A
Dividend Yield
2.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
Today 10:11 EDT
CAMBRIDGE, MA — March 26, 2026 — Shares of Sarepta Therapeutics (NASDAQ:SRPT) skyrocketed 34.98% in heavy trading today, marking the biotech giant's most explosive single-day gain in over two years....
Via
MarketMinute
The Second Act: A Deep-Dive into Corcept Therapeutics and the FDA Approval of Lifyorli
Today 9:37 EDT
March 26, 2026 Introduction Yesterday, March 25, 2026, Corcept Therapeutics (NASDAQ: CORT) reached a defining milestone that has fundamentally altered its investment profile: the early FDA approval of...
Via
Finterra
Topics
Economy
Intellectual Property
Performance
YTD
+8.1%
+8.1%
1 Month
-9.1%
-9.1%
3 Month
+7.8%
+7.8%
6 Month
+21.7%
+21.7%
1 Year
+35.6%
+35.6%
More News
Read More
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
World Trade
Novartis AG-Sponsored ADR (NYSE:NVS): A Methodical Pick for Steady Dividend Income
↗
March 13, 2026
Via
Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals
↗
February 19, 2026
Via
Chartmill
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF
↗
March 24, 2026
Via
The Motley Fool
Topics
ETFs
Retirement
3 ETFs Built for the Volatile Market We're Seeing in March 2026
↗
March 22, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Stocks
Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug
↗
March 20, 2026
Via
Benzinga
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
March 18, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients
↗
March 16, 2026
Via
Benzinga
VYMI: This International ETF Could Help You Earn Higher Dividends
↗
March 12, 2026
Via
The Motley Fool
Topics
ETFs
3 ETFs to Avoid as Oil Shock Hits Markets
↗
March 12, 2026
Via
MarketBeat
Topics
ETFs
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
March 10, 2026
Via
MarketMinute
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
March 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Lawsuit
Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now
↗
March 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
As Investors Flee U.S. Equities, This Global ETF Is Outperforming
↗
March 02, 2026
Via
MarketBeat
Topics
ETFs
Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement
↗
February 28, 2026
Via
Benzinga
Topics
Lawsuit
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
February 26, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies
↗
February 25, 2026
Via
The Motley Fool
Topics
Stocks
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
↗
February 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
Retirement
Arvinas (ARVN) Q4 2025 Earnings Call Transcript
↗
February 24, 2026
Via
The Motley Fool
Topics
Earnings
Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short
↗
February 23, 2026
Via
The Motley Fool
Topics
Stocks
Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades
↗
February 22, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer’s BRAFTOVI BREAKWATER Trial Delivers Landmark Survival Gains in Colorectal Cancer
February 19, 2026
Via
MarketMinute
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 149.70
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 03/26/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.